The prognostic value of a Methylome-based Malignancy Density Scoring System to predict recurrence risk in early-stage Lung Adenocarcinoma

Current NCCN guidelines do not recommend the use of adjuvant chemotherapy for stage IA lung adenocarcinoma patients with R0 surgery. However, 25% to 40% of patients with stage IA disease experience recurrence. Stratifying patients according to the recurrence risk may tailor adjuvant therapy and surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lu, Zhang, Jing, Yang, Guangjian, Xu, Haiyan, Lin, Jing, Shao, Lin, Li, Junling, Guo, Changyuan, Du, Yanru, Guo, Lei, Li, Xin, Han-Zhang, Han, Wang, Chenyang, Chuai, Shannon, Ye, Junyi, Kang, Qiaolin, Liu, Hao, Ying, Jianming, Wang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359091/
https://www.ncbi.nlm.nih.gov/pubmed/32685009
http://dx.doi.org/10.7150/thno.44229

Ejemplares similares

Ejemplares similares